Yumab
YUMAB is a contract research organization specializing in therapeutic antibody discovery and development. With nearly 30 years of expertise, YUMAB offers advanced antibody libraries, phage display technology, in vitro selection, high throughput screening, and AI-assisted antibody engineering and humanization services. Their platform supports biotech and pharma companies worldwide from target discovery to fully characterized lead candidates, focusing on developability and manufacturability optimization. YUMAB's flexible business model and comprehensive technology stack position it as a trusted partner in accelerating novel immunotherapy development.
Yumab
YUMAB is a contract research organization specializing in therapeutic antibody discovery and development. With nearly 30 years of expertise, YUMAB offers advanced antibody libraries, phage display technology, in vitro selection, high throughput screening, and AI-assisted antibody engineering and humanization services. Their platform supports biotech and pharma companies worldwide from target discovery to fully characterized lead candidates, focusing on developability and manufacturability optimization. YUMAB's flexible business model and comprehensive technology stack position it as a trusted partner in accelerating novel immunotherapy development.